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Abstract
Annexin II is a member of the annexin family of Ca2- and phospholipid-binding proteins which is particularly enriched
on early endosomal membranes and has been implicated in participating in endocytic events. In contrast to other endosomal
annexins the association of annexin II with its target membrane can occur in the absence of Ca2 in a manner depending on
the unique N-terminal domain of the protein. However, endosome binding of annexin II does not require formation of a
protein complex with the intracellular ligand S100A10 (p11) as an annexin II mutant protein (PM AnxII) incapable of
interacting with p11 is still present on endosomal membranes. Fusion of the N-terminal sequence of this PM AnxII (residues
1^27) to the conserved protein core of annexin I transfers the capability of Ca2-independent membrane binding to the
otherwise Ca2-sensitive annexin I. These results underscore the importance of the N-terminal sequence of annexin II for the
Ca2-independent endosome association and argue for a direct interaction of this sequence with an endosomal membrane
receptor. ß 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
Members of the annexin family of Ca2-binding
proteins are typically characterized by their Ca2-
regulated interaction with acidic phospholipids and
cellular membranes (for review see [1,2]). Binding of
the common annexin ligands (Ca2, phospholipids) is
mediated through a structurally conserved domain
within the individual proteins, the protein core.
Herein, segments of internal sequence homology,
the so-called annexin repeats, form type II and type
III Ca2-binding sites and Ca2 bound within these
sites serves a bridging function when annexins inter-
act peripherally with membrane phospholipids [3^5].
The second principal domain within an annexin mol-
ecule is formed by the N-terminal sequence which
precedes the protein core and varies in length and
sequence between di¡erent members. It is thought
to confer functional speci¢city to the individual an-
nexins and harbors binding sites for protein ligands
and sites for di¡erent posttranslational modi¢cations
(for review see [2]). Functions as diverse as a partic-
ipation in membrane tra⁄cking and the regulation of
blood coagulation have been proposed for di¡erent
annexins. While these proposals still await ¢nal proof
in in vivo systems almost all relate to the membrane
binding properties of the annexins and it appears
that the conserved annexin protein core is a module
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targeting annexins to membrane phospholipids for
speci¢c actions.
At least two members of the family, annexins I
and II, are present on endosomal membranes and a
participation in endocytosis and/or the organization
of the endosomal membrane system has been in-
ferred from these localizations and from functional
experiments using in vitro systems. Annexin I is a
substrate for the tyrosine kinase of the epidermal
growth factor (EGF) receptor with phosphorylation
most likely occurring in multivesicular endosomes.
This phosphorylation converts a Ca2-independently
associated form of annexin I into a species requiring
Ca2 for membrane association and it has been pro-
posed that this event is functionally linked to the
inward vesiculation in multivesicular endosomes
and thus the sorting of internalized receptors des-
tined for degradation [6]. However, the majority of
annexin I, at least in BHK [7] and HeLa cells (U.
Rescher and V. Gerke, unpublished observation), is
found associated with early endosomal membranes
and this association requires Ca2. In contrast to
this Ca2-sensitive and thus typical annexin-mem-
brane interaction a large fraction of the endosome
associated annexin II remains bound to the organelle
membrane in the presence of Ca2-chelating agents.
Moreover, an annexin II mutant protein with inacti-
vated type II Ca2-binding sites which is not able to
interact with membranes under physiological Ca2
levels binds endosomal membranes when expressed
transiently in BHK cells. This binding depends on
the presence of the unique N-terminal domain of
the protein as it is lost in a mutant protein lacking
the ¢rst 24 residues [8]. Most likely the atypical, i.e.
Ca2-independent, annexin-membrane association
requires a certain membrane composition and con-
¢guration as membrane bound annexin II is released
speci¢cally together with a group of actin-binding
proteins by sequestration of membrane cholesterol
[9].
Within most cells the major fraction of annexin II
is found in a tight heterotetrameric complex together
with the S100 protein S100A10 (p11). Complex for-
mation is highly speci¢c and is also mediated
through the unique N-terminal domain of annexin
II with residues 1^14 representing the entire
S100A10 binding site [10,11]. Although S100A10 is
also found on endosomal membranes (D. Zeuschner
and V. Gerke, unpublished observation) S100A10
binding is not required for the association of annexin
II with endosomes [8].
In addition to the biochemical and morphological
evidence there is also functional support for a role of
annexin II in endocytosis. The protein is transferred
e⁄ciently from a donor to an acceptor membrane in
homotypic endosome fusion assays [12] and pertur-
bation of its intracellular localization through ectopic
expression of a dominantly interfering annexin II
mutant results in a simultaneous perturbation of
the early endosome distribution in polarized
MDCK cells [13]. It has thus been postulated that
annexin II participates in organizing the early endo-
somal membrane system possibly by linking certain
domains of endosomal membranes to an underlying
actin cytoskeleton.
Since such a function is tightly linked to the Ca2-
independent membrane association of annexin II we
analyzed whether this atypical annexin property can
be transferred to the Ca2-sensitive annexin I. By
transiently expressing mutant proteins in BHK cells
and by elucidating their intracellular distribution
through subcellular fractionation we show that a se-
quence corresponding to residues 1^27 of annexin II
with an inactivated p11 binding site when fused to an
annexin I core can transfer the Ca2-independent
membrane binding. This leads to a model in which
di¡erent, Ca2-independent and Ca2-sensitive,
membrane interaction can regulate the association
of annexin II with endosomes.
2. Material and methods
2.1. Expression constructs
The wild-type and mutant annexin I and annexin
II expression constructs have been described [7,8,14].
For generation of the AnxII-AnxI chimera the N-
terminal domain of PM annexin II (nucleotides 39^
133, amino acid residues 1^27) was ampli¢ed by
PCR using the vector pCMV-PManxII [8] as tem-
plate. The vector pCMV-AnxI [7] containing the por-
cine annexin I cDNA was used for PCR ampli¢ca-
tion of the annexin I core domain (nucleotides 90^
1082, amino acid residues 37^346). PCR primers
were designed to generate a unique BamHI site at
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the 3P end of the PMAnxII and the 5P end of the
AnxI core product, respectively. Following appropri-
ate restriction digest the two annexin fragments were
ligated together generating a fusion of the N-termi-
nal PM annexin II encoding sequence in frame with
that of the annexin I core. The chimeric annexin
construct was subcloned into the eukaryotic expres-
sion vector pCMV5 to yield the pCMV/AnxII-
PM1ÿ27AnxI construct which was used for transfec-
tion of BHK-P3 cells.
2.2. Transfection of BHK-P3 cells
BHK-P3 cells (con£uent 60 cm2 culture dish) were
washed once in cold PBS and resuspended in 400 Wl
PBS. 200 Wl of the cell suspension were mixed with
10 Wg plasmid DNA. Electroporation was carried out
at 900 WF, 250 V using a Gene pulser II (Bio-Rad).
After a 10 min incubation on ice the cells were re-
suspended in warm DMEM and seeded in appropri-
ate density.
2.3. Fractionation of endosomal membranes from
BHK-P3 cells
The fractionation of endosomal membranes em-
ployed sucrose step gradients and was carried out
as described [15,16]. Membranes contained in the
isolated fractions were pelleted by ultracentrifugation
(150 000Ug, 15 min, 4‡C) and analyzed by SDS-
PAGE and Western blotting. Immunoblotting em-
ployed antibodies speci¢cally recognizing the ectopi-
cally expressed and not the endogenous annexin pro-
teins [7,14].
2.4. Membrane extractions
The Ca2 dependence of the annexin II-membrane
association was analyzed by collecting endosomal
membranes from a sucrose gradient prepared in the
presence and absence of 1 mM EDTA, respectively.
The isolated membranes were analyzed by SDS-
PAGE and Western blotting using the speci¢c anti-
bodies mentioned above.
The e¡ect of cholesterol on the membrane binding
of annexin II was investigated using membranes
from the early endosomal fraction which had been
isolated in the presence of EDTA. The early endo-
somal membranes were washed once in HBSE (20
mM HEPES pH 7.4, 150 mM NaCl, 2 mM
EGTA) and the membrane pellets were then resus-
pended in HBSE containing 0,5 mg/ml digitonin and
incubated for 30 min at room temperature. Extracted
membranes were collected by centrifugation
(150 000Ug, 15 min, 4‡C) and suspended in SDS-
sample bu¡er. The proteins released by digitonin
from the membranes into the supernatant were pre-
cipitated using TCA and then dissolved in SDS-sam-
ple bu¡er. All samples were analyzed by SDS-PAGE
and Western blotting employing the monoclonal
anti-annexin II antibody HH7 [14] for detection of
the endogenous BHK protein.
For characterization of the binding characteristics
of mutant annexin II or chimeric annexin II-annexin
I proteins, BHK-P3 cells were transfected transiently
with the relevant constructs two days before the ex-
traction experiments. Fractionation and extraction
were then performed as described above.
3. Results and discussion
Previous work employing mutant annexin II pro-
teins ectopically expressed in BHK cells had revealed
that the N-terminal sequence of residues 1^27 is in-
dispensable for the unique Ca2-independent mem-
brane binding displayed by this protein. Moreover,
mutations within this sequence which inactivate
S100A10 binding, the so-called p11-minus (PM) sub-
stitutions I6E and L7E, do not interfere with the
Ca2-independent endosome binding [8]. To analyze
whether this atypical annexin property is contained
within the unique N-terminal annexin II sequence
and can be transferred to another annexin whose
membrane binding is Ca2-sensitive we generated
the chimeric AnxIIPM1ÿ27AnxI protein. Here residues
1^27 of the PM annexin II sequence, i.e. the N-ter-
minal sequence incapable of binding S100A10, were
fused to the annexin I core domain thereby replacing
the unique N-terminal domain of annexin I (Fig. 1).
In parallel experiments the chimeric annexin pro-
tein AnxIIPM1ÿ27AnxI as well as its parental mole-
cules PM AnxII and AnxI were expressed transiently
in BHK cells. Subsequently, their distribution over
endosomal membranes was analyzed by fractionation
of such membranes in a sucrose £otation gradient
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and immunoblotting of the fractions obtained with
antibodies speci¢cally recognizing the ectopically ex-
pressed proteins and not the endogenous annexins.
Fig. 2 shows such comparative immunoblots of en-
dosomal membrane fractions prepared either in the
presence (3EDTA) or the absence (+EDTA) of mi-
cromolar Ca2 concentrations. As observed previ-
ously [7,8], endogenous (not shown) and ectopically
expressed annexin II (AnxII) remain associated with
early endosomal membranes in the presence of a
Ca2 chelator whereas annexin I (AnxI) requires
Ca2 for its interaction with early endosomes.
Ca2-independent endosome binding is also dis-
played by the PM AnxII derivative incapable of
binding S100A10. Thus complex formation with en-
dogenous S100A10 is not a prerequisite for the endo-
some-annexin II interaction occurring in the absence
of Ca2. However, when compared to the isolation
of endosomes carried out in the absence of EDTA
the fraction of early endosome-associated PM annex-
in II is considerably reduced in the absence of Ca2.
This is not due to an alteration of the fractionation
properties of early endosomes as a typical marker of
this compartment, the early endosome associated
antigen EEA1 [17], is una¡ected by the EDTA treat-
ment. Thus it appears that the Ca2-independent
binding of annexin II to early endosomes is at least
in part facilitated or stabilized by formation of the
annexin II-S100A10 complex.
Even though displaying a reduced membrane bind-
ing in the absence of Ca2 PM annexin II still be-
haves di¡erent when compared to annexin I which
shows no detectable membrane association in the
presence of EDTA. However, the unique properties
of PM annexin II can be transferred to the annexin I
protein when the N-terminal annexin I domain is
replaced by the N-terminal PMAnxII sequence in
the AnxIIPM1ÿ27AnxI chimera (Fig. 2). Thus, when
fused to an annexin core the N-terminal annexin II
sequence covering residues 1^27 is su⁄cient for me-
diating the unique property of Ca2-independent
membrane association. This argues for the existence
of a receptor structure on endosomal membranes
which speci¢cally interacts with the annexin II se-
quence contained within the N-terminal 27 residues
of PM annexin II. As the Ca2-independent binding
Fig. 1. Construction of the AnxIIPM1ÿ27AnxI chimera. Annexin structures are shown schematically with the conserved protein core de-
picted as four rectangles representing the four annexin repeats. Sequences of the N-terminal domains are given in the one letter code.
As compared to the wild-type sequence of the human protein PM annexin II contains two amino acid substitutions (I6E and L7E)
which render the S100A10 (p11) binding site non-functional. Residues 1^27 of this PM annexin II were placed in front of an annexin
I core domain (amino acids 37^346) to generate the AnxIIPM1ÿ27AnxI chimera (AIIPM1ÿ27AI). Residues phosphorylated in vitro by
serine/threonine- or tyrosine-speci¢c protein kinases are given in green and red, respectively.
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is not observed for annexin II when arti¢cial phos-
pholipid bilayers are employed in liposome pelleting
assays at physiological pH [18] such receptor struc-
ture is speci¢c for cellular membranes. Collectively
these observations point towards the existence of a
speci¢c endosomal receptor (lipid membrane struc-
ture or membrane associated/bound protein) which
recognizes the N-terminal sequence of annexin II.
Ca2-independent binding of annexin II to cellular
membranes requires a certain lipid composition
and/or structure with membrane cholesterol being
of prime importance [9]. To analyze whether this
property is also mediated through the N-terminal
PMAnxII sequence we subjected early endosomal
membranes prepared from BHK cells transiently
expressing di¡erent mutant annexins to extraction
with the cholesterol-binding drug digitonin. While
the pool of endogenous (not shown) and ectopically
expressed annexin II associated with the endosome
fraction in the absence of Ca2 remains bound upon
further wash with EGTA-containing bu¡ers it is al-
most quantitatively extracted by the digitonin treat-
ment (Fig. 3). The endosome bound PM annexin II
Fig. 2. Association of ectopically expressed wild-type and mu-
tant annexin proteins with membrane fractions from BHK-P3
cells. Wild-type annexin II (AnxII), wild-type annexin I (AnxI),
the PM annexin II mutant (PM AnxII) or the AnxIIPM1ÿ27AnxI
chimera was ectopically expressed in BHK-P3 cells. Two days
following transfection membranes present in a postnuclear
supernatant (PNS) of the lysed cells were subjected to separa-
tion in a £otation gradient. Cell lysis and gradient fractionation
were carried out either in the presence (+) or the absence (3)
of 1 mM EDTA. Gradient fractions enriched in heavy mem-
branes (HM), early endosomes (EE) or late endosomes (LE)
were analyzed for the presence of the di¡erent annexin deriva-
tives by immunoblotting with antibodies speci¢cally recognizing
the ectopically expressed proteins. Immunoblots with antibodies
against the early endosomal protein EEA1 served as a control
to verify the enrichment of early endosomes in the EE fraction
in the di¡erent experiments (only one such control is shown).
Note that the AnxIIPM1ÿ27AnxI chimera shows a distribution
among the membrane fractions which is similar to that of PM
AnxII. In contrast, AnxI fails to co-fractionate with cellular
membranes in the presence of EDTA.
Fig. 3. Release of membrane bound annexin II and di¡erent
mutant annexin II derivatives by digitonin. PM annexin II or
the AnxIIPM1ÿ27AnxI chimera was expressed transiently in
BHK-P3 and endosomal membranes of the transfected cells
were subjected to £otation gradient separation in the presence
of EDTA. Membranes collected from the early endosomal frac-
tion were treated with digitonin- or EGTA-containing bu¡ers
and centrifuged again to separate the remaining membranes (P)
from the proteins released into the supernatant (S). Immuno-
blotting using speci¢c antibodies revealed the presence of en-
dogenous annexin II (AnxII) as well as the ectopically expressed
PM annexin II (PM AnxII) and AnxIIPM1ÿ27AnxI (AII-
PM1ÿ27AI) derivatives in the di¡erent fractions. Note that en-
dogenous annexin II, PM annexin II and the AnxIIPM1ÿ27AnxI
chimera are extracted almost quantitatively from the early en-
dosomal membranes by digitonin. In contrast, membrane
bound caveolin is resistant to extraction under these conditions.
BBAMCR 14678 27-11-00 Cyaan Magenta Geel Zwart
J. Ko«nig, V. Gerke / Biochimica et Biophysica Acta 1498 (2000) 174^180178
behaves identically while membrane associated cav-
eolin is resistant to digitonin treatment under the
conditions chosen. Again the unique property of an-
nexin II and its PM derivative is contained within the
N-terminal sequence as the endosome associated
fraction of AnxIIPM1ÿ27AnxI shows the same digito-
nin sensitivity (Fig. 3). Thus, the Ca2-independent
association of annexin II with endosomal membranes
is mediated through the N-terminal 27 residues
which interact with receptor structures found within
domains rich in or stabilized through membrane cho-
lesterol. Such an association of annexin II with cho-
lesterol-rich membrane domains (or protein receptors
therein) is in line with the ¢nding that the Ca2-in-
dependently associated pool of endosome bound an-
nexin II is resistant to Triton X-100 treatment at 4‡C
(data not shown) thus showing a behavior typical of
components of sphingolipid- and cholesterol-rich
membrane rafts [19,20]. The binding of annexin II
(and the AnxIIPM1ÿ27AnxI chimera) to cholesterol-
rich domains of endosomal membranes is di¡erent
to what has been observed for plasma membrane
associated annexin II. While the former can occur
in the absence of Ca2 the latter requires Ca2 and
Fig. 4. Schematic model depicting di¡erent modes of annexin II-membrane interactions. Monomeric annexin II (blue) and the hetero-
tetrameric annexin II-p11 complex can bind to negatively charged phospholipid head groups in a peripheral and Ca2-regulated man-
ner with the divalent cations serving a bridging function. Endosomal membranes contain a receptor structure (?) most likely within
cholesterol-rich domains which can interact with the N-terminal domain of annexin II in a Ca2-independent manner. It appears that
a unique sequence contained within the ¢rst 27 residues of annexin II but di¡erent from the S100A10 (p11) binding site, i.e. amino
acids 15^27, represents the binding site for the endosomal receptor.
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thus most likely an additional interaction of the an-
nexin protein core with negatively charged phospho-
lipids [21,22].
Collectively, the results obtained with mutant and
chimeric annexin proteins point towards di¡erent
modes of interaction of annexin II with endosomal
membranes which are regulated di¡erently by Ca2.
As depicted schematically in Fig. 4, both the annexin
II monomer and the annexin II-S100A10 complex
can bind peripherally and Ca2 dependently to neg-
atively charged membrane phospholipids with the
latter ^ due to the F-actin binding of annexin II
[23,24] ^ having the capability of linking the mem-
brane surface to underlying actin ¢laments. Alterna-
tively or additionally the N-terminal sequence of the
protein can interact with a receptor structure in the
absence of Ca2. The functional integrity of the re-
ceptor structure as an annexin II-binding platform
requires membrane cholesterol but does not depend
on S100A10 binding. Similar modes of action are
also likely to occur at the plasma membrane
although here the association with cholesterol-rich
membrane domains (or a receptor therein) requires
an additional Ca2-dependent interaction. Thus it
appears that a function of annexin II at its target
membrane is strictly dependent on Ca2 binding to
the protein only in the case of the plasma membrane.
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